Home » Topics » Regulatory » Patents

Patents
RSS

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Roche discloses new 5-HT2B antagonists

Feb. 13, 1998

Chiroscience describes series with PDE/TNF-inhibitory properties

Feb. 13, 1998

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Nonpeptide GnRH antagonists prepared at Merck & Co.

Feb. 13, 1998

Antipsychotic drugs in development at Janssen

Feb. 13, 1998

DuPont Merck claims new CRF antagonists

Feb. 13, 1998

Sankyo researches new antidiabetic agents

Feb. 13, 1998

Antitumor arabinofuranosylcytosines from Yamasa

Feb. 13, 1998

Zeneca's new antibacterial agents active against resistant pathogens

Feb. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...